Lantus is a prescription medication used to treat type 1 and type 2 diabetes. Lantus is a long-acting form of insulin and works by replacing the insulin that is normally produced by the body and by helping the body to use sugar for energy. It also stops the liver from producing more sugar.
This medication comes in an injectable form and is usually used once daily.
Common side effects include low blood sugar, redness and skin thickening at the injection site, and weight gain.
Lantus Drug Class
Lantus is part of the drug class:
Related Clinical Trials
- Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy
- LANN-study: Lantus, Amaryl, Novorapid, Novomix Study
- JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients
- Glycemic Optimization Treatment Study
- Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)
- A Study of LY2963016 in Healthy Participants
- Lantus in the Treatment of Type 1 Diabetes Children
- A Study in Adults With Type 2 Diabetes
- Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks
- A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy Subjects
- Comparison of Lantus and NPH Insulin in the Dawn Phenomenon
- Perioperative Insulin Glargine Dosing Study
- A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to Lantus in Healthy Subjects
- A Study in Adults With Type 1 Diabetes
- A Study to Compare LY2963016 to Lantus After a Single Dose to Subjects With Type 1 Diabetes Mellitus